Article Details
Retrieved on: 2021-04-30 13:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Remdesivir, marketed as Veklury, drove the increase, pulling in $1.5 billion during the quarter. While that marked a dip compared with nearly $2 billion in ...
Article found on: www.fiercepharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here